Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shoko Futami-Suda"'
Autor:
Kentaro Watanabe, Kazunari Suzuki, Tatsuya Suzuki, Yoshimasa Igari, Shoko Futami-Suda, Junya Aoyama, Hiroshi Nakano, Makoto Ohara, Motoshi Ouchi, Masao Hashimoto
Publikováno v:
Clinical Biochemistry. 47:1128-1131
Background Bile acids (BAs) play important roles in glucose regulation and energy homeostasis via G protein-coupled receptors, such as enteroendocrine L cell TGR5. The aim of the present study was to investigate the relationship between postprandial
Autor:
Hiroshi Nakano, Kentaro Watanabe, Tatsuya Suzuki, Yoshimasa Igari, Kazunari Suzuki, Shoko Futami-Suda, Kenzo Oba, Motoshi Ouchi
Publikováno v:
Journal of Diabetes Mellitus. :338-345
We evaluated the effect of sitagliptin on vascular endothelial function in Japanese type 2 diabetes patients without cardiovascular disease. Subjects included 24 Japanese type 2 diabetes patients without cardiovascular disease. This study was a prosp
Autor:
Kazunari Suzuki, Hiroshi Nakano, Motoshi Ouchi, Kentaro Watanabe, Ken-ichi Sekimizu, Naofumi Yamamoto, Kenzo Oba, Shoko Futami-Suda, Tatsuya Suzuki
Publikováno v:
European Journal of Clinical Investigation. 41:465-473
Eur J Clin Invest 2011; 41 (5): 465–473 Abstract Background We evaluated the relationship between glucose fluctuation and vascular endothelial function. Material and methods We recruited 25 healthy individuals with no family history of diabetes (14
Autor:
Makoto Ohara, Hiroshi Nakano, Misako Tsunoda, Kazunari Suzuki, Motoshi Ouchi, Jun Norose, Kenzo Oba, Kentaro Watanabe, Shoko Futami-Suda, Tatsuya Suzuki, Ken-ichi Sekimizu
Publikováno v:
Journal of Nippon Medical School. 77:59-61
Ultrasonography is widely used to evaluate atherosclerosis. Therefore, many ultrasound parameters exist, each with its own clinical implications. Many reports have shown that these ultrasound parameters are useful for evaluating the progression of at
Autor:
Tetsuro Onishi, Tatsuya Suzuki, Yoshimasa Igari, Kenzo Oba, Shoko Futami-Suda, Hiroshi Nakano, Misako Tsunoda-Kubota, Motoshi Ouchi, Hidetoshi Yamashita, Makoto Ohara, Junya Aoyama, Kazuhito Ishii
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 433
Background To assess the relationship between the serum level of 1,5-anhydroglucitol (1,5-AG), a marker of postprandial hyperglycemia, and the ratio of the urinary activity of N-acetyl-β- d -glucosaminidase to creatinine (NAG index) in subjects with
Autor:
Mitsuhiro Watanabe, Kenzo Oba, Masao Hashimoto, Hiroshi Nakano, Joan Auwerx, Tatsuya Suzuki, Kentaro Watanabe, Yoshimasa Igari, Shoko Futami-Suda
Publikováno v:
Journal of Hypo & Hyperglycemia.
The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome Bile acid–binding resins (BABRs) improve hyperglycemia in patients with type 2 diabetes, and the BABR colesevelam has been approved by the U.S. F
Autor:
Shoko Futami-Suda, Motoshi Ouchi, Yoshiaki Kigawa, Tatsuya Suzuki, Hiroshi Nakano, Kazunari Suzuki, Kenzo Oba, Jun Norose, Hiroko Yasuoka, Kentaro Watanabe
Publikováno v:
Geriatricsgerontology international. 8(3)
Aim: The aim of this study was to evaluate the difference in daily blood glucose profiles between once- and twice-daily regimens of a moderate daily dose of glibenclamide or gliclazide in elderly patients with type 2 diabetes. Methods: Daily blood gl
Autor:
Shoko Futami-Suda, Tatsuya Suzuki, Hiroomi Yoshimatsu, Kenzo Oba, Ken-ichi Sekimizu, Yoshiaki Kigawa, Kazunari Suzuki, Hiroshi Nakano, Motoshi Ouchi, Jun Norose
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 75(2)
Colestimide has been reported to lower blood glucose levels in patients with type 2 diabetes and hypercholesterolemia. We investigated the mechanism of the hypoglycemic activity of colestimide by examining changes in serum cholecystokinin (CCK) and i
Autor:
Yoshimasa Igari, Shoko Futami-Suda, Tatsuya Suzuki, Kazunari Suzuki, Hiroko Yasuoka, Yoshiaki Kigawa, Hiroshi Nakano, Kentaro Watanabe, Noriaki Matsumura, Kenzo Oba, Motoshi Ouchi
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 74(5)
Background: Colestimide has been reported to lower blood glucose levels in patients with type 2 diabetes complicated by hypercholesterolemia. Aim: To examine the mechanism by which colestimide decreases plasma glucose levels in the above patients. Me
Autor:
Noriaki Matsumura, Kentaro Watanabe, Yoshimasa Igari, Yoshiaki Kigawa, Hiroshi Nakano, Shoko Futami-Suda, Motoshi Ouchi, Tatsuya Suzuki, Kenzo Oba, Kazunari Suzuki
Publikováno v:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 74(1)